Skip to main content
RDY logo

Dr. Reddy's Laboratories Limited

RDYNYSEHealthcareDrug Manufacturers - Specialty & Generic

$13.07Today:- (-)1Y −10.73%

As of Oct 16, 2026 close

Market cap
$10.75B
P/E (TTM)
31.70
Forward P/E
55.86
Dividend yield
1.14%
52-week range
$11.36$15.67
Volume (live)
-
Avg. volume (3M)
2.94M

Dr. Reddy's Laboratories (RDY) Cash Flow Statement

In fiscal 2026 (fiscal year ended Mar 31, 2026), Dr. Reddy's Laboratories generated INR 56.65B of operating cash flow and spent INR 24.54B on capital expenditures. That left free cash flow of INR 32.10B, up 166.8% from INR 12.03B a year earlier, or 9.6% of revenue. It paid INR 7.01B in dividends.

Dr. Reddy's Laboratories Cash Flow Statement Analysis

Values in billions INR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Dr. Reddy's Laboratories Limited (RDY) - Annual data in billions INR
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating Activities
Net Income45.0957.2555.6845.0723.5717.2419.5018.809.8112.04
Depreciation & Amortization21.6817.0614.8412.6411.8212.8012.4712.1911.7111.28
Deferred Income Tax0.0019.5416.1915.308.739.18-1.473.654.542.61
Stock Based Compensation0.000.420.410.400.590.580.520.390.450.40
Change in Working Capital-12.24-29.99-20.18-7.86-18.50-10.72-7.54-5.77-8.96-5.35
Change in Accounts Receivable-7.07-10.28-8.05-5.75-17.012.08-12.451.80-2.103.04
Change in Inventory-9.05-12.75-18.45-2.65-9.91-12.40-1.49-8.50-3.23-6.33
Change in Accounts Payable2.940.003.460.004.412.860.00-1.800.000.00
Change in Other Working Capital0.94-6.95-0.570.55-3.42-8.976.402.73-5.730.98
Other Operating Activities2.12-17.85-0.57-6.6718.0621.526.35-0.550.490.54
Net Cash from Operating Activities56.6546.4345.4358.8828.1135.7029.8428.7018.0321.51
Investing Activities
Capital Expenditures-24.54-34.40-27.44-18.87-14.66-9.74-6.12-7.49-11.04-40.98
Acquisitions-2.99-53.41-0.010.00-0.33-15.510.000.541.75-0.10
Purchases of Investments-49.21-254.46-41.65-136.17-88.97-75.42-111.92-78.57-68.43-49.65
Sales/Maturities of Investments20.63279.5825.94112.8177.7779.53111.7076.2964.0471.60
Other Investing Activities1.47-2.281.78-6.680.871.220.141.51-1.200.67
Net Cash from Investing Activities-70.53-58.08-40.28-41.37-26.39-22.66-4.92-7.73-14.88-18.47
Financing Activities
Debt Repayment21.3123.20-4.95-20.40-0.79-3.74-19.17-15.180.88-5.22
Common Stock Issued0.420.190.810.370.33-0.920.000.000.000.00
Common Stock Repurchased0.00-1.390.000.000.00-1.19-0.47-0.540.00-15.69
Dividends Paid-7.01-6.66-6.65-4.98-4.15-4.15-3.92-4.00-3.99-3.39
Other Financing Activities-1.333.57-2.27-1.85-1.35-2.08-1.61-1.61-1.3320.61
Net Cash from Financing Activities13.4018.91-3.76-26.86-2.42-0.30-25.16-21.33-4.44-3.69
Summary
Effect of Forex Changes on Cash-0.380.22-0.060.290.730.11-0.030.040.06-0.49
Net Change in Cash-0.887.491.39-9.070.0312.75-0.27-0.31-1.24-1.14
Cash at Beginning of Period15.947.115.7814.8514.821.962.232.543.784.92
Cash at End of Period15.0614.597.115.7814.8514.821.962.232.543.78
Free Cash Flow32.1012.0318.0040.0113.4525.9623.7321.216.99-19.47
Supplemental Disclosures
Interest Paid-3.482.271.851.351.32----
Income Taxes Paid-19.9920.0510.717.445.72----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Dr. Reddy's Laboratories Cash Flow

What is Dr. Reddy's Laboratories's free cash flow?

Dr. Reddy's Laboratories generated free cash flow of INR 32.10B in fiscal 2026 (fiscal year ended Mar 31, 2026), operating cash flow of INR 56.65B minus INR 24.54B of capital expenditures. That was up 166.8% from INR 12.03B a year earlier. Free cash flow equaled 9.6% of revenue.

How much does Dr. Reddy's Laboratories spend on capital expenditures?

Dr. Reddy's Laboratories spent INR 24.54B on capital expenditures in fiscal 2026, compared with INR 34.40B a year earlier. That equals 43.3% of operating cash flow.

Does Dr. Reddy's Laboratories pay dividends or buy back shares?

Yes. In fiscal 2026 Dr. Reddy's Laboratories returned INR 7.01B in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition